Stem cells have the ability to regenerate, repair, and replenish other cells, which provides hope for the possibility of replacing diseased cells. One of the richest sources of stem cells is found in the umbilical cord and the placenta after a baby is delivered.
An organization established in 2013 under the name Camden RAD, LLC, today known as Stem Cell Innovations (SCI) www.scia.io, has assumed a critical job in stem cell innovative work around the globe and has led its very own residential and global contextual analyses to facilitate the research in this field. SCI’s activities have specifically added to advancements in the field, and additionally to new stem cell discoveries around the globe. To finance a research and make stem cell treatments generally accessible, SCI has chosen to join stem cell research with another innovation – the blockchain technology.
The information gained through research provides us with a deeper understanding of why abnormalities develop in cells in the first place. In addition to helping us understand why diseases occur, research and development in stem cell technology can bring with it new advancements in the drug industry treat conditions without harmful side effects such as those brought about by chemotherapy.
To date, four types of stem cells have been identified as being able to provide stem cell-related treatments and therapies. These types include embryonic stem cells, tissue-specified adult stem cells, mesenchymal synthetic stem cells, and induced pluripotent stem cells. Of all the four cell types, embryonic stem cells are the purest form of stem cell. They are extracted from embryos and stored until needed. Embryonic stem cells can form into 220 known different cell types, providing the opportunity for a broad range of applications. Tissue-specified adult stem cells are limited in their application in medical treatments, and more information is needed about potential applications in the future
The Elixir Of Life
The first successful cord blood transplant (CBT) was done in 1988 in a child with Fanconi anemia. The cells in this type of blood boost the immunity of both the mother and baby in preparation for labor. Being able to collect and store that blood for future use is a growing trend in medicine. Cord blood banking (also known as stem cell banking) is the process of collecting the cord blood and cryogenically freezing its stem cells.
Stem cell banking allows parents to safeguard their children against possible medical issues in the future by ensuring they have access to their own pure stem cells if needed. However, the complexity and cost of the current stem cell banking options present many barriers to parents who wish to take advantage of this medical technology. In addition to furthering research, SCI plans to offer stem cell banking through its stem cell application ecosystem. Parents will be able to order a collection kit, schedule courier pickup, and sign up for stem cell storage, all through one secure application. Because SCI will offer a worldwide network of stem cell storage and therapy options to its users, it is uniquely positioned to streamline the process of stem cell banking for parents and lower the costs for collection and storage.
Prior to advancements in stem cell research, doctors collected bone marrow for transplants from a patient’s own bone marrow, but with the successes in stem cell research, medical professionals can now harvest stem cells from blood for the purposes of bone marrow transplants. The impacts of stem cells on bone marrow transplants means that patients do not have to wait for a donor and painful surgical procedures can be avoided. Stem cells can provide us with a unique approach to therapy in a variety of conditions. We’re confident that such research and advancement will continue to change the way the medical community views many of the world’s most prevalent diseases.
For more information about SCI and the ICO, visit www.scia.io.